RIZE Share Price Performance
CA$0.03
-0.01 (-25.00%)
Price CA$0.03
Share Pricen/a
Rize Oncology Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
RIZE Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Rize Oncology Inc. Key Details
About RIZE
- Founded
- 2018
- Employees
- n/a
- CEO
- WebsiteView website
Rize Oncology Inc. engages in the development of oncology therapeutics. It develops STS-201, a small-molecule drug for the treatment of soft tissue sarcoma. The company was formerly known as GeneTether Therapeutics Inc. and changed its name to Rize Oncology Inc. in January 2025. Rize Oncology Inc. was founded in 2018 and is based in Kelowna, Canada.
